Stoke Therapeutics Inc buy BTIG Research
Start price
19.03.26
/
50%
€27.60
Target price
19.03.27
€33.95
Performance (%)
-8.12%
Price
17.07.26
€25.36
Summary
This prediction is currently active. With a performance of -8.12%, the BUY prediction by BTIG_Research is trending in the wrong direction. This prediction currently runs until 19.03.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | - | - |
| iShares Core DAX® | 0,85 % | 0,39 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % |
| iShares S&P 500 | 0,06 % | 0,78 % |
Comments by BTIG_Research for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (STOK) had its "buy" rating reaffirmed by BTIG Research. They now have a $39.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by BTIG_Research for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€27.17
11.05.26
11.05.26
€33.17
11.05.27
11.05.27
-4.86%
17.07.26
17.07.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€19.00
05.11.25
05.11.25
€33.93
05.11.26
05.11.26
33.47%
17.07.26
17.07.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€26.60
14.10.25
14.10.25
€33.70
14.10.26
14.10.26
-4.66%
17.07.26
17.07.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€15.60
18.08.25
18.08.25
€23.93
18.08.26
18.08.26
62.56%
17.07.26
17.07.26